0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug-Loadable Embolic Microspheres Market Research Report 2026
Published Date: 2026-02-11
|
Report Code: QYRE-Auto-26W17661
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Loadable Embolic Microspheres Market Research Report 2024
BUY CHAPTERS

Global Drug-Loadable Embolic Microspheres Market Research Report 2026

Code: QYRE-Auto-26W17661
Report
2026-02-11
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug-Loadable Embolic Microspheres Market Size

The global Drug-Loadable Embolic Microspheres market was valued at US$ 1481 million in 2025 and is anticipated to reach US$ 2634 million by 2032, at a CAGR of 8.7% from 2026 to 2032.

Drug-Loadable Embolic Microspheres Market

Drug-Loadable Embolic Microspheres Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug-Loadable Embolic Microspheres competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Drug-loadable embolic microsphere is a therapeutic embolic agent used to block tumor blood flow and drug delivery. Loadable embolic microspheres delivered by transarterial chemoembolization (TACE) serve as a therapeutic embolic to stop blood flow to tumors and a drug delivery vehicle.
In 2024, global Drug-loadable embolic microsphere production reached approximately 1067 L, with an average global market price of around US$1300 per mL. The single-line production capacity for drug-loadable embolic microspheres is approximately 20-100 liters/year. The industry's gross profit margin is approximately 60% to 80%. Raw materials (polymers such as PVA and drugs) account for the largest portion of the cost structure, approximately 30% to 40%, with the remainder comprising production consumables and packaging materials, labor costs, and manufacturing expenses. Upstream raw material suppliers provide key raw materials such as biodegradable polymers and drug-loaded materials; downstream players primarily include hospitals and medical institutions (as end users, performing TACE treatments) and dealers and distributors (responsible for regional product sales and promotion).
The drug-loadable embolic microsphere segment is maturing from a niche adjunct to a core interventional oncology platform that couples mechanical occlusion with localized pharmacotherapy. Advances in polymer science and controlled-release formulation have improved particle uniformity and intratumoral drug delivery predictability, which enhances procedural reproducibility and clinician confidence. Broad clinical adoption depends less on incremental device features than on robust clinical evidence and regulatory clarity; products backed by multicenter studies and clear procedural protocols are more likely to be integrated into standard care pathways. Manufacturing reliability—consistent batch-to-batch performance, scalable production, and stringent quality systems—is a critical commercial differentiator, since clinicians and hospitals prioritize devices with dependable supply and consistent behavior. Cost and accessibility remain meaningful constraints in lower-resource settings, preserving a role for simpler embolics even as high-value drug-eluting platforms gain ground in advanced centers. Strategically, winners will be those combining differentiated drug-delivery chemistry, demonstrable clinical benefit, and pragmatic manufacturing scale-up, enabling integration with image-guided workflows and personalized therapeutic strategies.
This report delivers a comprehensive overview of the global Drug-Loadable Embolic Microspheres market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug-Loadable Embolic Microspheres. The Drug-Loadable Embolic Microspheres market size, estimates, and forecasts are provided in terms of sales volume (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug-Loadable Embolic Microspheres market comprehensively. Regional market sizes by Type, by Application, by Size, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug-Loadable Embolic Microspheres manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Drug-Loadable Embolic Microspheres Market Report

Report Metric Details
Report Name Drug-Loadable Embolic Microspheres Market
Accounted market size in 2025 US$ 1481 million
Forecasted market size in 2032 US$ 2634 million
CAGR 8.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Drug-eluting Microspheres
  • Radioactive Microspheres
Segment by Size
  • 1G (<100μm)
  • 2 G (≥100μm)
by Application
  • Primary Liver Cancer
  • Colorectal Cancer Liver Metastasis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, Suzhou Hengrui Medical Equipment, ABK Biomedical, Mermaid Medical, Cardiolink Science, Suzhou Haowei Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Size, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Drug-Loadable Embolic Microspheres manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Drug-Loadable Embolic Microspheres sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Drug-Loadable Embolic Microspheres Market growing?

Ans: The Drug-Loadable Embolic Microspheres Market witnessing a CAGR of 8.7% during the forecast period 2026-2032.

What is the Drug-Loadable Embolic Microspheres Market size in 2032?

Ans: The Drug-Loadable Embolic Microspheres Market size in 2032 will be US$ 2634 million.

Who are the main players in the Drug-Loadable Embolic Microspheres Market report?

Ans: The main players in the Drug-Loadable Embolic Microspheres Market are Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, Suzhou Hengrui Medical Equipment, ABK Biomedical, Mermaid Medical, Cardiolink Science, Suzhou Haowei Medical Technology

What are the Application segmentation covered in the Drug-Loadable Embolic Microspheres Market report?

Ans: The Applications covered in the Drug-Loadable Embolic Microspheres Market report are Primary Liver Cancer, Colorectal Cancer Liver Metastasis, Others

What are the Type segmentation covered in the Drug-Loadable Embolic Microspheres Market report?

Ans: The Types covered in the Drug-Loadable Embolic Microspheres Market report are Drug-eluting Microspheres, Radioactive Microspheres

1 Drug-Loadable Embolic Microspheres Market Overview
1.1 Product Definition
1.2 Drug-Loadable Embolic Microspheres by Type
1.2.1 Global Drug-Loadable Embolic Microspheres Market Value by Type: 2025 vs 2032
1.2.2 Drug-eluting Microspheres
1.2.3 Radioactive Microspheres
1.3 Drug-Loadable Embolic Microspheres by Size
1.3.1 Global Drug-Loadable Embolic Microspheres Market Value by Size: 2025 vs 2032
1.3.2 1G (<100μm)
1.3.3 2 G (≥100μm)
1.4 Drug-Loadable Embolic Microspheres by Application
1.4.1 Global Drug-Loadable Embolic Microspheres Market Value by Application: 2025 vs 2032
1.4.2 Primary Liver Cancer
1.4.3 Colorectal Cancer Liver Metastasis
1.4.4 Others
1.5 Global Drug-Loadable Embolic Microspheres Market Size Estimates and Forecasts
1.5.1 Global Drug-Loadable Embolic Microspheres Revenue 2021–2032
1.5.2 Global Drug-Loadable Embolic Microspheres Sales 2021–2032
1.5.3 Global Drug-Loadable Embolic Microspheres Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Drug-Loadable Embolic Microspheres Market Competition by Manufacturers
2.1 Global Drug-Loadable Embolic Microspheres Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drug-Loadable Embolic Microspheres Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drug-Loadable Embolic Microspheres, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Product Types and Applications
2.7 Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Date of Entry into the Industry
2.8 Global Drug-Loadable Embolic Microspheres Market Competitive Situation and Trends
2.8.1 Global Drug-Loadable Embolic Microspheres Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drug-Loadable Embolic Microspheres Players Market Share by Revenue
2.8.3 Global Drug-Loadable Embolic Microspheres Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug-Loadable Embolic Microspheres Market Scenario by Region
3.1 Global Drug-Loadable Embolic Microspheres Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drug-Loadable Embolic Microspheres Sales by Region: 2021–2032
3.2.1 Global Drug-Loadable Embolic Microspheres Sales by Region: 2021–2026
3.2.2 Global Drug-Loadable Embolic Microspheres Sales by Region: 2027–2032
3.3 Global Drug-Loadable Embolic Microspheres Revenue by Region: 2021–2032
3.3.1 Global Drug-Loadable Embolic Microspheres Revenue by Region: 2021–2026
3.3.2 Global Drug-Loadable Embolic Microspheres Revenue by Region: 2027–2032
3.4 North America Drug-Loadable Embolic Microspheres Market Facts & Figures by Country
3.4.1 North America Drug-Loadable Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drug-Loadable Embolic Microspheres Sales by Country (2021–2032)
3.4.3 North America Drug-Loadable Embolic Microspheres Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug-Loadable Embolic Microspheres Market Facts & Figures by Country
3.5.1 Europe Drug-Loadable Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drug-Loadable Embolic Microspheres Sales by Country (2021–2032)
3.5.3 Europe Drug-Loadable Embolic Microspheres Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug-Loadable Embolic Microspheres Market Facts & Figures by Region
3.6.1 Asia Pacific Drug-Loadable Embolic Microspheres Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drug-Loadable Embolic Microspheres Sales by Region (2021–2032)
3.6.3 Asia Pacific Drug-Loadable Embolic Microspheres Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug-Loadable Embolic Microspheres Market Facts & Figures by Country
3.7.1 Latin America Drug-Loadable Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drug-Loadable Embolic Microspheres Sales by Country (2021–2032)
3.7.3 Latin America Drug-Loadable Embolic Microspheres Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug-Loadable Embolic Microspheres Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug-Loadable Embolic Microspheres Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drug-Loadable Embolic Microspheres Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drug-Loadable Embolic Microspheres Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug-Loadable Embolic Microspheres Sales by Type (2021–2032)
4.1.1 Global Drug-Loadable Embolic Microspheres Sales by Type (2021–2026)
4.1.2 Global Drug-Loadable Embolic Microspheres Sales by Type (2027–2032)
4.1.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2021–2032)
4.2 Global Drug-Loadable Embolic Microspheres Revenue by Type (2021–2032)
4.2.1 Global Drug-Loadable Embolic Microspheres Revenue by Type (2021–2026)
4.2.2 Global Drug-Loadable Embolic Microspheres Revenue by Type (2027–2032)
4.2.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2021–2032)
4.3 Global Drug-Loadable Embolic Microspheres Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drug-Loadable Embolic Microspheres Sales by Application (2021–2032)
5.1.1 Global Drug-Loadable Embolic Microspheres Sales by Application (2021–2026)
5.1.2 Global Drug-Loadable Embolic Microspheres Sales by Application (2027–2032)
5.1.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2021–2032)
5.2 Global Drug-Loadable Embolic Microspheres Revenue by Application (2021–2032)
5.2.1 Global Drug-Loadable Embolic Microspheres Revenue by Application (2021–2026)
5.2.2 Global Drug-Loadable Embolic Microspheres Revenue by Application (2027–2032)
5.2.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2021–2032)
5.3 Global Drug-Loadable Embolic Microspheres Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific Drug-Loadable Embolic Microspheres Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Company Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo Drug-Loadable Embolic Microspheres Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 Merit Medical
6.3.1 Merit Medical Company Information
6.3.2 Merit Medical Description and Business Overview
6.3.3 Merit Medical Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merit Medical Drug-Loadable Embolic Microspheres Product Portfolio
6.3.5 Merit Medical Recent Developments/Updates
6.4 Varian
6.4.1 Varian Company Information
6.4.2 Varian Description and Business Overview
6.4.3 Varian Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Varian Drug-Loadable Embolic Microspheres Product Portfolio
6.4.5 Varian Recent Developments/Updates
6.5 Sirtex Medical
6.5.1 Sirtex Medical Company Information
6.5.2 Sirtex Medical Description and Business Overview
6.5.3 Sirtex Medical Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sirtex Medical Drug-Loadable Embolic Microspheres Product Portfolio
6.5.5 Sirtex Medical Recent Developments/Updates
6.6 Suzhou Hengrui Medical Equipment
6.6.1 Suzhou Hengrui Medical Equipment Company Information
6.6.2 Suzhou Hengrui Medical Equipment Description and Business Overview
6.6.3 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Portfolio
6.6.5 Suzhou Hengrui Medical Equipment Recent Developments/Updates
6.7 ABK Biomedical
6.7.1 ABK Biomedical Company Information
6.7.2 ABK Biomedical Description and Business Overview
6.7.3 ABK Biomedical Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ABK Biomedical Drug-Loadable Embolic Microspheres Product Portfolio
6.7.5 ABK Biomedical Recent Developments/Updates
6.8 Mermaid Medical
6.8.1 Mermaid Medical Company Information
6.8.2 Mermaid Medical Description and Business Overview
6.8.3 Mermaid Medical Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Mermaid Medical Drug-Loadable Embolic Microspheres Product Portfolio
6.8.5 Mermaid Medical Recent Developments/Updates
6.9 Cardiolink Science
6.9.1 Cardiolink Science Company Information
6.9.2 Cardiolink Science Description and Business Overview
6.9.3 Cardiolink Science Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cardiolink Science Drug-Loadable Embolic Microspheres Product Portfolio
6.9.5 Cardiolink Science Recent Developments/Updates
6.10 Suzhou Haowei Medical Technology
6.10.1 Suzhou Haowei Medical Technology Company Information
6.10.2 Suzhou Haowei Medical Technology Description and Business Overview
6.10.3 Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Product Portfolio
6.10.5 Suzhou Haowei Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug-Loadable Embolic Microspheres Industry Chain Analysis
7.2 Drug-Loadable Embolic Microspheres Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug-Loadable Embolic Microspheres Production Mode & Process Analysis
7.4 Drug-Loadable Embolic Microspheres Sales and Marketing
7.4.1 Drug-Loadable Embolic Microspheres Sales Channels
7.4.2 Drug-Loadable Embolic Microspheres Distributors
7.5 Drug-Loadable Embolic Microspheres Customer Analysis
8 Drug-Loadable Embolic Microspheres Market Dynamics
8.1 Drug-Loadable Embolic Microspheres Industry Trends
8.2 Drug-Loadable Embolic Microspheres Market Drivers
8.3 Drug-Loadable Embolic Microspheres Market Challenges
8.4 Drug-Loadable Embolic Microspheres Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Drug-Loadable Embolic Microspheres Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Drug-Loadable Embolic Microspheres Market Value by Size (US$ Million), 2025 vs 2032
 Table 3. Global Drug-Loadable Embolic Microspheres Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Drug-Loadable Embolic Microspheres Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Drug-Loadable Embolic Microspheres Sales (L) of Key Manufacturers (2021–2026)
 Table 6. Global Drug-Loadable Embolic Microspheres Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Drug-Loadable Embolic Microspheres Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Drug-Loadable Embolic Microspheres Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Drug-Loadable Embolic Microspheres Average Price (US$/mL) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Drug-Loadable Embolic Microspheres, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Product Types and Applications
 Table 13. Global Key Manufacturers of Drug-Loadable Embolic Microspheres, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Drug-Loadable Embolic Microspheres Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug-Loadable Embolic Microspheres Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Drug-Loadable Embolic Microspheres Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Drug-Loadable Embolic Microspheres Sales by Region (L), 2021–2026
 Table 19. Global Drug-Loadable Embolic Microspheres Sales Market Share by Region (2021–2026)
 Table 20. Global Drug-Loadable Embolic Microspheres Sales by Region (L), 2027–2032
 Table 21. Global Drug-Loadable Embolic Microspheres Sales Market Share by Region (2027–2032)
 Table 22. Global Drug-Loadable Embolic Microspheres Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2021–2026)
 Table 24. Global Drug-Loadable Embolic Microspheres Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2027–2032)
 Table 26. North America Drug-Loadable Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Drug-Loadable Embolic Microspheres Sales by Country (L), 2021–2026
 Table 28. North America Drug-Loadable Embolic Microspheres Sales by Country (L), 2027–2032
 Table 29. North America Drug-Loadable Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Drug-Loadable Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Drug-Loadable Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Drug-Loadable Embolic Microspheres Sales by Country (L), 2021–2026
 Table 33. Europe Drug-Loadable Embolic Microspheres Sales by Country (L), 2027–2032
 Table 34. Europe Drug-Loadable Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Drug-Loadable Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Drug-Loadable Embolic Microspheres Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Drug-Loadable Embolic Microspheres Sales by Region (L), 2021–2026
 Table 38. Asia Pacific Drug-Loadable Embolic Microspheres Sales by Region (L), 2027–2032
 Table 39. Asia Pacific Drug-Loadable Embolic Microspheres Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Drug-Loadable Embolic Microspheres Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Drug-Loadable Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Drug-Loadable Embolic Microspheres Sales by Country (L), 2021–2026
 Table 43. Latin America Drug-Loadable Embolic Microspheres Sales by Country (L), 2027–2032
 Table 44. Latin America Drug-Loadable Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Drug-Loadable Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Drug-Loadable Embolic Microspheres Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Drug-Loadable Embolic Microspheres Sales by Country (L), 2021–2026
 Table 48. Middle East and Africa Drug-Loadable Embolic Microspheres Sales by Country (L), 2027–2032
 Table 49. Middle East and Africa Drug-Loadable Embolic Microspheres Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Drug-Loadable Embolic Microspheres Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Drug-Loadable Embolic Microspheres Sales (L) by Type (2021–2026)
 Table 52. Global Drug-Loadable Embolic Microspheres Sales (L) by Type (2027–2032)
 Table 53. Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2021–2026)
 Table 54. Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2027–2032)
 Table 55. Global Drug-Loadable Embolic Microspheres Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Drug-Loadable Embolic Microspheres Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2021–2026)
 Table 58. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2027–2032)
 Table 59. Global Drug-Loadable Embolic Microspheres Price (US$/mL) by Type (2021–2026)
 Table 60. Global Drug-Loadable Embolic Microspheres Price (US$/mL) by Type (2027–2032)
 Table 61. Global Drug-Loadable Embolic Microspheres Sales (L) by Application (2021–2026)
 Table 62. Global Drug-Loadable Embolic Microspheres Sales (L) by Application (2027–2032)
 Table 63. Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2021–2026)
 Table 64. Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2027–2032)
 Table 65. Global Drug-Loadable Embolic Microspheres Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Drug-Loadable Embolic Microspheres Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2021–2026)
 Table 68. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2027–2032)
 Table 69. Global Drug-Loadable Embolic Microspheres Price (US$/mL) by Application (2021–2026)
 Table 70. Global Drug-Loadable Embolic Microspheres Price (US$/mL) by Application (2027–2032)
 Table 71. Boston Scientific Company Information
 Table 72. Boston Scientific Description and Business Overview
 Table 73. Boston Scientific Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 74. Boston Scientific Drug-Loadable Embolic Microspheres Product
 Table 75. Boston Scientific Recent Developments/Updates
 Table 76. Terumo Company Information
 Table 77. Terumo Description and Business Overview
 Table 78. Terumo Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 79. Terumo Drug-Loadable Embolic Microspheres Product
 Table 80. Terumo Recent Developments/Updates
 Table 81. Merit Medical Company Information
 Table 82. Merit Medical Description and Business Overview
 Table 83. Merit Medical Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 84. Merit Medical Drug-Loadable Embolic Microspheres Product
 Table 85. Merit Medical Recent Developments/Updates
 Table 86. Varian Company Information
 Table 87. Varian Description and Business Overview
 Table 88. Varian Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 89. Varian Drug-Loadable Embolic Microspheres Product
 Table 90. Varian Recent Developments/Updates
 Table 91. Sirtex Medical Company Information
 Table 92. Sirtex Medical Description and Business Overview
 Table 93. Sirtex Medical Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 94. Sirtex Medical Drug-Loadable Embolic Microspheres Product
 Table 95. Sirtex Medical Recent Developments/Updates
 Table 96. Suzhou Hengrui Medical Equipment Company Information
 Table 97. Suzhou Hengrui Medical Equipment Description and Business Overview
 Table 98. Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 99. Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product
 Table 100. Suzhou Hengrui Medical Equipment Recent Developments/Updates
 Table 101. ABK Biomedical Company Information
 Table 102. ABK Biomedical Description and Business Overview
 Table 103. ABK Biomedical Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 104. ABK Biomedical Drug-Loadable Embolic Microspheres Product
 Table 105. ABK Biomedical Recent Developments/Updates
 Table 106. Mermaid Medical Company Information
 Table 107. Mermaid Medical Description and Business Overview
 Table 108. Mermaid Medical Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 109. Mermaid Medical Drug-Loadable Embolic Microspheres Product
 Table 110. Mermaid Medical Recent Developments/Updates
 Table 111. Cardiolink Science Company Information
 Table 112. Cardiolink Science Description and Business Overview
 Table 113. Cardiolink Science Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 114. Cardiolink Science Drug-Loadable Embolic Microspheres Product
 Table 115. Cardiolink Science Recent Developments/Updates
 Table 116. Suzhou Haowei Medical Technology Company Information
 Table 117. Suzhou Haowei Medical Technology Description and Business Overview
 Table 118. Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Sales (L), Revenue (US$ Million), Price (US$/mL), and Gross Margin (2021–2026)
 Table 119. Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Product
 Table 120. Suzhou Haowei Medical Technology Recent Developments/Updates
 Table 121. Key Raw Materials Lists
 Table 122. Raw Materials Key Suppliers Lists
 Table 123. Drug-Loadable Embolic Microspheres Distributors List
 Table 124. Drug-Loadable Embolic Microspheres Customers List
 Table 125. Drug-Loadable Embolic Microspheres Market Trends
 Table 126. Drug-Loadable Embolic Microspheres Market Drivers
 Table 127. Drug-Loadable Embolic Microspheres Market Challenges
 Table 128. Drug-Loadable Embolic Microspheres Market Restraints
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources
 Table 132. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug-Loadable Embolic Microspheres
 Figure 2. Global Drug-Loadable Embolic Microspheres Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Drug-Loadable Embolic Microspheres Market Share by Type: 2025 & 2032
 Figure 4. Drug-eluting Microspheres Product Picture
 Figure 5. Radioactive Microspheres Product Picture
 Figure 6. Global Drug-Loadable Embolic Microspheres Market Value by Size (US$ Million), 2021–2032
 Figure 7. Global Drug-Loadable Embolic Microspheres Market Share by Size: 2025 vs 2032
 Figure 8. 1G (<100μm) Product Picture
 Figure 9. 2 G (≥100μm) Product Picture
 Figure 10. Global Drug-Loadable Embolic Microspheres Market Value by Application (US$ Million), 2021–2032
 Figure 11. Global Drug-Loadable Embolic Microspheres Market Share by Application: 2025 & 2032
 Figure 12. Primary Liver Cancer
 Figure 13. Colorectal Cancer Liver Metastasis
 Figure 14. Others
 Figure 15. Global Drug-Loadable Embolic Microspheres Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Drug-Loadable Embolic Microspheres Market Size (US$ Million), 2021–2032
 Figure 17. Global Drug-Loadable Embolic Microspheres Sales (L), 2021–2032
 Figure 18. Global Drug-Loadable Embolic Microspheres Average Price (US$/mL), 2021–2032
 Figure 19. Drug-Loadable Embolic Microspheres Report Years Considered
 Figure 20. Drug-Loadable Embolic Microspheres Sales Share by Manufacturers in 2025
 Figure 21. Global Drug-Loadable Embolic Microspheres Revenue Share by Manufacturers in 2025
 Figure 22. Top 5 and Top 10 Global Drug-Loadable Embolic Microspheres Players: Market Share by Revenue in Drug-Loadable Embolic Microspheres in 2025
 Figure 23. Drug-Loadable Embolic Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 24. Global Drug-Loadable Embolic Microspheres Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 25. North America Drug-Loadable Embolic Microspheres Sales Market Share by Country (2021–2032)
 Figure 26. North America Drug-Loadable Embolic Microspheres Revenue Market Share by Country (2021–2032)
 Figure 27. United States Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Canada Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Europe Drug-Loadable Embolic Microspheres Sales Market Share by Country (2021–2032)
 Figure 30. Europe Drug-Loadable Embolic Microspheres Revenue Market Share by Country (2021–2032)
 Figure 31. Germany Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. France Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. U.K. Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Italy Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Russia Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Asia Pacific Drug-Loadable Embolic Microspheres Sales Market Share by Region (2021–2032)
 Figure 37. Asia Pacific Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2021–2032)
 Figure 38. China Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Japan Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. South Korea Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. India Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Australia Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. China Taiwan Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Southeast Asia Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Drug-Loadable Embolic Microspheres Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Drug-Loadable Embolic Microspheres Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Colombia Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Drug-Loadable Embolic Microspheres Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Drug-Loadable Embolic Microspheres Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Drug-Loadable Embolic Microspheres Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Drug-Loadable Embolic Microspheres by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Drug-Loadable Embolic Microspheres by Type (2021–2032)
 Figure 58. Global Drug-Loadable Embolic Microspheres Price (US$/mL) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Drug-Loadable Embolic Microspheres by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Drug-Loadable Embolic Microspheres by Application (2021–2032)
 Figure 61. Global Drug-Loadable Embolic Microspheres Price (US$/mL) by Application (2021–2032)
 Figure 62. Drug-Loadable Embolic Microspheres Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension